» Articles » PMID: 36686483

Recurrent Implantation Failure: A Comprehensive Summary from Etiology to Treatment

Overview
Specialty Endocrinology
Date 2023 Jan 23
PMID 36686483
Authors
Affiliations
Soon will be listed here.
Abstract

Implantation is the first step in human reproduction. Successful implantation depends on the crosstalk between embryo and endometrium. Recurrent implantation failure (RIF) is a clinical phenomenon characterized by a lack of implantation after the transfer of several embryos and disturbs approximately 10% couples undergoing fertilization and embryo transfer. Despite increasing literature on RIF, there is still no widely accepted definition or standard protocol for the diagnosis and treatment of RIF. Progress in predicting and preventing RIF has been hampered by a lack of widely accepted definitions. Most couples with RIF can become pregnant after clinical intervention. The prognosis for couples with RIF is related to maternal age. RIF can be caused by immunology, thrombophilias, endometrial receptivity, microbiome, anatomical abnormalities, male factors, and embryo aneuploidy. It is important to determine the most possible etiologies, and individualized treatment aimed at the primary cause seems to be an effective method for increasing the implantation rate. Couples with RIF require psychological support and appropriate clinical intervention. Further studies are required to evaluate diagnostic method and he effectiveness of each therapy, and guide clinical treatment.

Citing Articles

The study on the clinical efficacy of endometrial receptivity analysis and influence factors of displaced window of implantation.

Xu S, Diao H, Xiong Y, Zhang C, Zhang Y, Zhang Y Sci Rep. 2025; 15(1):7326.

PMID: 40025209 PMC: 11873133. DOI: 10.1038/s41598-025-91745-y.


Correlation of MicroRNA-31 with Endometrial Receptivity in Patients with Repeated Implantation Failure of Fertilization and Embryo Transfer.

Tan Y, Du B, Chen X, Chen M Organogenesis. 2025; 21(1):2460263.

PMID: 39988813 PMC: 11853553. DOI: 10.1080/15476278.2025.2460263.


Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure.

Garmendia J, De Sanctis C, Hajduch M, De Sanctis J Int J Mol Sci. 2025; 26(3).

PMID: 39941063 PMC: 11818386. DOI: 10.3390/ijms26031295.


The impact of long-acting Gonadotropin-releasing hormone agonist pretreatment on the clinical pregnancy outcomes of hormone replacement therapy-frozen embryo transfer in recurrent implantation failure patients with and without polycystic ovary....

Huang C, Yan Y, Mei J, Jiang Y, Sun H, Xing J BMC Pregnancy Childbirth. 2025; 25(1):133.

PMID: 39934706 PMC: 11817544. DOI: 10.1186/s12884-025-07264-1.


The Effect of Autologous Platelet Rich Plasma on Endometrial Receptivity: A Narrative Review.

Stefanovic M, Vukomanovic P, Kutlesic R, Trenkic M, Dimitrov V, Stefanovic A Medicina (Kaunas). 2025; 61(1).

PMID: 39859116 PMC: 11767130. DOI: 10.3390/medicina61010134.


References
1.
Moffett A, Colucci F . Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol Rev. 2015; 267(1):283-97. DOI: 10.1111/imr.12323. View

2.
Cimadomo D, Craciunas L, Vermeulen N, Vomstein K, Toth B . Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists. Hum Reprod. 2020; 36(2):305-317. DOI: 10.1093/humrep/deaa317. View

3.
Coughlan C, Clarke H, Cutting R, Saxton J, Waite S, Ledger W . Sperm DNA fragmentation, recurrent implantation failure and recurrent miscarriage. Asian J Androl. 2015; 17(4):681-5. PMC: 4492063. DOI: 10.4103/1008-682X.144946. View

4.
Bilgory A, Shalom-Paz E, Atzmon Y, Aslih N, Shibli Y, Estrada D . Diode Laser Hysteroscopic Metroplasty for Dysmorphic Uterus: a Pilot Study. Reprod Sci. 2021; 29(2):506-512. DOI: 10.1007/s43032-021-00607-1. View

5.
. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril. 2008; 90(5 Suppl):S66-8. DOI: 10.1016/j.fertnstert.2008.08.089. View